A Prospective, Single-center, Observational Study Aiming to Assess the Predictive Role of Flow Mediated Dilatation in Acute Coronary Syndromes, Combined With Echocardiographic and Biochemical Indices: The Novel Cor-IS Technology Will Also be Evaluated (FLARE-ACS)

Aristotle University Of Thessaloniki

Status

Enrolling

Conditions

Acute Coronary Syndromes

Endothelial Function (FMD)

Flow Mediated Dilation

Treatments

Diagnostic Test: Observation group

Study type

Observational

Funder types

Other

Identifiers

NCT06890013

198/31.5.2024

Details and patient eligibility

About

A prospective, single-center, observational study aiming to assess the predictive role of flow mediated dilatation in acute coronary syndromes, combined with echocardiographic and biochemical indices. The novel Cor-IS technology will also be evaluated.

Enrollment

100 estimated patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Age > 18 years
Patients hospitalized due to acute coronary syndrome (STEMI, NSTEMI)
Capability of providing written informed consent
Patients able to comply with the follow-up schedule of the study

Exclusion criteria

Patients with acute coronary syndromes classified as MINOCA, or type II myocardial infarction
Patients with rare acute coronary syndrome types, such as spontaneous coronary artery dissection or Takotsubo syndrome
Patients with congenital heart disease
Age > 85 years
Patients with end stage chronic kidney disease
Patients with active malignancy or autoimmune diseases which limit their survival
Patients with expected survival < 1 year due to other reasons
Suboptimal echocardiographic windows
Inability to provide written consent
Inability to comply with the follow-up schedule of the study
Pregnancy
Use of intravenous drugs